<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="82910">
  <stage>Registered</stage>
  <submitdate>19/06/2008</submitdate>
  <approvaldate>1/08/2008</approvaldate>
  <actrnumber>ACTRN12608000379314</actrnumber>
  <trial_identification>
    <studytitle>Bee venom allergy desensitisation study</studytitle>
    <scientifictitle>A single centre, randomised, controlled Phase 1/2 study of adults with bee venom allergy to evaluate the safety and efficacy of an Advax-adjuvanted bee venom desensitisation regime</scientifictitle>
    <utrn />
    <trialacronym>BEE001</trialacronym>
  </trial_identification>
  <conditions>
    <healthcondition>Bee venom allergy</healthcondition>
    <conditioncode>
      <conditioncode1>Inflammatory and Immune System</conditioncode1>
      <conditioncode2>Allergies</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Bee venom desensitisation therapy administered per usual outpatient desensitisation therapy regimen involving weekly subcutaneous administrations of  bee venom extract (0.001 microgram increasing in steps to 0.01, 0.1, 0.3, 1, 3, 6, 10, 15, 20, 25, 30, 35, 40, 45, 50, 70, then 100 microgram as tolerated) formulated with Advax adjuvant 10mg</interventions>
    <comparator>Bee venom desensitisation therapy administered per usual outpatient desensitisation therapy regimen involving weekly subcutaneous administrations of bee venom extract (0.001 microgram increasing in steps to 0.01, 0.1, 0.3, 1, 3, 6, 10, 15, 20, 25, 30, 35, 40, 45, 50, 70, then 100 microgram as tolerated)</comparator>
    <control>Active</control>
    <interventioncode>Treatment: Other</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Bee venom desensitisation as assessed by bee venom skin challenge test</outcome>
      <timepoint>3, 6, 9, and 12 months after start of Bee venom desensitisation therapy</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>Safety assessment as assessed by frequency of local (i.e injection site reactions) and systemic adverse events (e.g. fever, myalgia, fatigue) and serious adverse events (e.g. anaphylaxis, hospitalisation)</outcome>
      <timepoint>12 months</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>Known history of bee sting allergy</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>65</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Previous bee venom desensitisation therapy
Women of childbearing potential unless using a reliable and appropriate contraceptive method, specifically oral contraceptive pill, intrauterine device or mechanical barrier device. 
Pregnant or lactating women. 
Concurrent immunosuppressive therapy, including corticosteroids (with the exception of topically applied/inhaled steroids).</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint>Safety/efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Phase 1 / Phase 2</phase>
    <anticipatedstartdate>1/01/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>60</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>Vaxine pty Ltd</primarysponsorname>
    <primarysponsoraddress>Flinders Medical Centre
Adelaide 5042</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>Self funded/Unfunded</fundingtype>
      <fundingname />
      <fundingaddress />
      <fundingcountry />
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>This study will determine the most effective way to administer bee venom desensitisation therapy for people with serious life threatening bee venom allergy</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Flinders Clinical Research Ethics Committee</ethicname>
      <ethicaddress>Flinders Medical Centre
Adelaide 5042</ethicaddress>
      <ethicapprovaldate />
      <hrec />
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Assoc. Prof. Bob Heddle</name>
      <address>Flinders Medical Centre
Adelaide 5042</address>
      <phone>0882044572</phone>
      <fax />
      <email>bob.heddle@fmc.sa.gov.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Assoc. Prof. Bob Heddle</name>
      <address>Flinders Medical Centre
Adelaide 5042</address>
      <phone>0882044572</phone>
      <fax />
      <email>bob.heddle@fmc.sa.gov.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>Professor Nikolai Petrovsky</name>
      <address>Flinders Medical Centre
Adelaide 5042</address>
      <phone>0882044572</phone>
      <fax>0882045987</fax>
      <email>nikolai.petrovsky@flinders.edu.au</email>
      <country>Australia</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>